News
09 August 2017

Help us develop a new mobile health app

People with depression, epilepsy and multiple sclerosis (MS) are being asked to contribute to a major research project by completing a five-minute survey on health technology.

*The questionnaire is now closed*

The questionnaire is part of RADAR-CNS (Remote Assessment of Disease and Relapse – Central Nervous System), an international research programme which is developing new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.Researchers working on RADAR-CNS are asking for contributions from people with depression, epilepsy and multiple sclerosis (MS).  The survey results will be used to inform the development of a mobile application (app) for the research project which appropriately reflects how people with these conditions use mobile technology.

According to Maximilian Kerz, a researcher at King’s College London who is leading development of the app: “We’re hoping to hear from a wide range of people with depression, epilepsy and multiple sclerosis.  I’d like to urge anyone who has one of these conditions to take five minutes to complete the survey, and to help spread the word – everyone’s views are important, whether or not you already use mobile technology or health apps.”

Complete the survey here by 30 August 2017. Results are anonymous and respondents are not required to disclose their medical condition to participate.

People with depression, epilepsy, and multiple sclerosis (MS) and their carers are being involved at each stage of development of RADAR-CNS, which is jointly led by King’s College London and Janssen Pharmaceutica NV.  The project is funded by the Innovative Medicines Initiative (a Public Private Partnership established between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union).

Find out more about RADAR-CNS at the project website. For any questions about the project contact info@radar-cns.org.